GlassScriptPhysician profile
Ronald L Asher
NPI 1437122322
$436.32
in general payments reported to CMS, 2019-2025
13 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.55 · 2020: $51.89 · 2021: $83.23 · 2022: $31.15 · 2023: $50.68 · 2024: $41.18 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $128.38 | 2019-2025 | |
| Novo Nordisk INC | $90.52 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Daiichi Sankyo INC. | $58.85 | 2021 | |
| Mylan Specialty L.P. | $24.59 | 2019-2020 | |
| Amgen INC. | $24.46 | 2019 | |
| Abbott Laboratories | $24.39 | 2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $18.98 | 2023 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $16.99 | 2022 | |
| Astellas Pharma US INC | $14.91 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.81 | 2021 | |
| Lilly USA, LLC | $11.28 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.16 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$75,050.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Asher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.